Oncology Data Advisor

June is #NationalCancerSurvivorsMonth. Watch as @DarcyBurbage, Oncology Clinical Nurse Specialist, shares advice for supporting #cancer #survivors and helping them navigate unique challenges throughout the #survivorship continuum. Watch here! youtu.be/gJOF1QnuLdY

Recently, @i3health provided an #educational activity that challenged clinicians’ #proficiency in the use of #immunotherapy for recurrent/metastatic head and neck squamous cell #carcinoma (#HNSCC). Learn more about the #outcomes and knowledge gains here: oncdata.com/hnscc-outcomes/

In this Letter From the Editor, @RahulBanerjeeMD reflects on the groundbreaking findings of the CHALLENGE trial, which show that structured #exercise interventions can yield survival benefits rivaling those of established #cancer therapies. Read here! oncdata.com/letter-from-th…

In honor of #SarcomaAwarenessMonth in July, @richardriedelmd and @candace_haddox share updates to their @i3health Dedifferentiated #Liposarcoma (#DDLPS) Task Force. Watch here: youtu.be/ilcaR0lyms8?si… And view the full Task Force and position statement: i3health.com/course-informa…

This #GlioblastomaAwarenessDay, Dr. Ajay Abad of @RoswellPark highlights #SurVaxM, a novel survivin-targeted #vaccine for glioblastoma, and the importance of continued collaboration to move the needle forward in this aggressive disease. Watch here! youtu.be/DLuyFDSAd5Q

#ASCO25 showcased #AI across the #oncology spectrum, from optimizing #prostate cancer therapy (@arteraAI) to streamlining research (#ASCOmind) to paving the way for targeted screening (@RambamHCC @TechnionLive). Read @WaqasHaqueMD's thoughts here! oncdata.com/ai-at-asco/ @ASCO

On 7/17 and 8/5, @AmanChauhanMD is giving an i3 Health webinar exploring the diagnosis and treatment of #neuroendocrine tumors (#NETs). Here, he shares a preview of the exciting advances he'll be discussing. Watch here and learn how to register! youtu.be/EqFNE3qnTdo

The #FDA has granted accelerated approval to #sunvozertinib for adults with locally advanced or metastatic non–small cell #LungCancer (#NSCLC) harboring #EGFR exon 20 insertion mutations. Learn more about the #approval and the #WUKONG1B trial here: oncdata.com/sunvozertinib-…

Watch as @SFreedlandMD and @jgong15 of @CedarsSinai explore the phase 3 #CHALLENGE trial, presented at #ASCO25, which showed encouraging results for the impact of a structured #exercise program on disease-free survival in #colon #cancer. Watch here! youtu.be/bIUmM2ZpwNk

The #FDA has granted accelerated approval to #linvoseltamab-gcpt for the treatment of adults with relapsed or refractory multiple #myeloma. Learn more about the #approval and the #LINKERMM1 trial here: oncdata.com/linvoseltamab-…

How does @AmericanCancer use #AI to improve patient care? Watch as @WaqasHaqueMD speaks with @arifkamalmd, Chief Patient Officer, about the intersection of #technology, patient #advocacy, and the future of cancer care. Watch here! youtu.be/RFisPwWFsIs?si… #AmericanCancerSociety

In this #ASCO25 video, Dr. Manali Patel of @Stanford discusses her team's presentation outlining the dangers that #NaturalDisasters pose to #cancer care and how health systems can develop comprehensive #emergency #preparedness plans. Watch here! youtu.be/_XAcbXwMrww @ASCO

The #FDA has granted accelerated approval to #datopotamab deruxtecan-dlnk for locally advanced or metastatic EGFR-mutated non–small cell #LungCancer (#NSCLC). Learn more about the #approval and the #TROPION-Lung trials here: oncdata.com/datopotamab-de…

Watch as Dr. Abigail Zamorano (@abigailflynt) of @McGovernMed discusses her #ASCO25 poster highlighting the unique distress experienced by #caregivers of patients with #gynecologic cancers and what clinicians can do to help support caregivers. Watch here! youtube.com/watch?v=FTjF5V…

In honor of #WorldKidneyCancerDay, Dr. David Maj shares his #ASCO25 presentation on the role of #IMDC prognostic factors in metastatic #renal cell carcinoma (#RCC) after first-line #immunotherapy and the implications for patient counseling. Watch here! youtu.be/m1IWA68DGsc?si…

The #FDA has approved #pembrolizumab for use as a #perioperative treatment in adults with resectable locally advanced head and neck squamous cell #carcinoma (#HNSCC). This marks the first FDA #approval for HNSCC in 6 years! Learn more here: oncdata.com/pembrolizumab-…

Happy #PrideMonth from OncData! In this video, Board members @lghazal and @HundalJasmin share perspectives on #inclusive cancer care for #LGBTQ+ patients, including unique challenges and progress being made in ensuring equitable care for all. Watch here! youtu.be/Zxo-RDSjRzQ?si…

Happy #NursingAssistantsDay! Watch as Maria Badillo (@jaymbsanycgmai1) talks with her colleagues Erika Toledo and Kimberly Hartig-Balderas about their unique roles as nursing assistants in oncology care and research at @MDAndersonNews. Watch here! youtu.be/ZV_RJSel32Q?si…

The #FDA has granted approval to #mitomycin intravesical solution for adult patients with recurrent low-grade intermediate-risk non–muscle invasive #BladderCancer (LG-IR-NMIBC). Learn more about the #approval and the #ENVISION trial here: oncdata.com/mitomycin-intr…

This #PrideMonth, Oncology Data Advisor stands with the LGBTQ+ community in the fight against cancer. We're dedicated to providing the latest data and insights to address disparities in oncology care. 🏳️‍🌈 Your story matters. Your health matters. Happy Pride! #LGBTQHealth #Oncology